DMD and myotonic dystrophy type 1: In neuromuscular disorders such as Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), AOCs promote exon skipping or RNA interference, restoring dystrophin expression or reducing toxic RNA repeats in vivo [315].